Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Margarita Vlachou is active.

Publication


Featured researches published by Margarita Vlachou.


Letters in Drug Design & Discovery | 2005

A Facile Synthesis of C2-Substituted Pyrrolo[2,3-f]quinolines with Cytotoxic Activity

Andrew Tsotinis; Margarita Vlachou; Spyridon Zouroudis; A. Jeney; Ferenc Timár; David E. Thurston; Christos Roussakis

An expeditious four-step synthesis of the 1H-pyrrolo[2,3-f]quinoline-2- carboxamides (5a-h) is described. Readily available 6-quinolinecarboxaldehyde is converted to the parent acid (6) by nucleophilic attack of the azido-ester (9) and intramolecular cyclization of (10) followed by hydrolysis of the methyl ester (11). The cytotoxicity of the target molecules (5a-h) was evaluated in four tumour cell lines in vitro. One compound (5d) showed sufficient activity (IC50 = 10.2 ?M) in the human non-small cell lung cell line NSCLC-N16-L16 to be worthy of further study.


Heterocycles | 2002

A New Ring-forming Methodology for the Synthesis of Bioactive Pyrroloquinoline Derivatives

Andrew Tsotinis; Margarita Vlachou; Lloyd R. Kelland; David E. Thurston

A new, efficient, two-step method for the synthesis of bioactive pyrroloquinolines is described. Readily available nitroquinolines, bearing the nitro moiety in the carbocyclic ring, are treated with 4-chlorophenoxyacetonitrile in the presence of potassium tert-butoxide/THF to give the analogous vicarious nucleophilic substitution products (5, 8 and 11). These, in turn, are subjected to catalytic hydrogenation to produce 1H-pyrrolo[2,3-f]quinoline (6), 3H-pyrrolo[3,2-f]quinoline (9) and 1H-pyrrolo[3,2-h]quinoline (12) in good yields and relatively short reaction times. The differential activity of two N-alkylated 1H-pyrrolo[2,3-f]quinolines (1) in cisplatin resistant cell lines compared to the corresponding parent lines suggests that these might be useful leads for developing agents for use in drug resistant diseases.


European Journal of Pharmaceutical Sciences | 2002

An expeditious synthesis of cytotoxic pyrroloisoquinoline derivatives. Structure-activity comparative studies with isomeric pyrroloquinolines.

Margarita Vlachou; Andrew Tsotinis; Lloyd R. Kelland; David E. Thurston

A number of pyrroloisoquinolines have been prepared by reaction of 5-nitroisoquinoline with vinylmagnesium bromide followed by N-alkylation with the appropriate 2-chloro-N,N-dialkylethylamine. Their cytotoxicity was evaluated in a number of ovarian cell lines and compared to their analogous isomeric pyrroloquinolines. Two of the new compounds, 7c and 7d, are selective toward the A2780 cisplatin-resistant line.


Letters in Drug Design & Discovery | 2005

Aromatic polycationic molecules with restricted conformations: An alternative approach to antiherpes agents

Andrew Tsotinis; Margarita Vlachou; Andreas Eleutheriades; Peter J. Garratt; Ashley J. Ibbett; Yiu-Fai Ng; Christophe Pannecouque; Myriam Witvrouw; Erik De Clercq

A series of aromatic polycationic molecules were synthesised and tested as potential non-classical antiherpes agents. Analogue (4) had a high potency in all four of the HSV cell lines used and is far more potent than ribavirin. The fact that none of the new compounds show any selectivity for HSV-2 over HSV-1 may imply that there is no intervention of a HSV-2 glycoprotein C (gC) dependent pathway.


Journal of Medicinal Chemistry | 2006

Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines

Andrew Tsotinis; Margarita Vlachou; Demetris P. Papahatjis; Theodora Calogeropoulou; Spyros P. Nikas; Peter J. Garratt; Vincent Piccio; Stefan Vonhoff; Kathryn Davidson; Muy-Teck Teh; David Sugden


Chemistry Letters | 2001

A New Ring-Forming Methodology for the Synthesis of Conformationally Constrained Bioactive Molecules

Demetris P. Papahatjis; Spyros P. Nikas; Andrew Tsotinis; Margarita Vlachou; Alexandros Makriyannis


Chemical & Pharmaceutical Bulletin | 2002

Synthesis of N1-Phenethyl Substituted Indole Derivatives as New Melatoninergic Agonists and Antagonists

Andrew Tsotinis; Margarita Vlachou; Andreas Eleutheriades; Effie Prinea; Darren Ebreo; David Sugden


Chemistry Letters | 2003

Design and Synthesis of Two Cytotoxic Analogs of the Novel Pyrrolo[1′,2′:1,2][1,4]diazepin [7,6-b]indol-5(6H)-one Nucleus

Andrew Tsotinis; Margarita Vlachou; Konstantinos Kiakos; John A. Hartley; David E. Thurston


Letters in Drug Design & Discovery | 2006

C5,C6-Disubstituted 1H-Indole-2-Carboxamides: Synthesis and Cytotoxic Activity in the Human Non-Small Lung Cancer Cell Line NSCLC-N16-L16

Andrew Tsotinis; Maria Gerasimopoulou; Margarita Vlachou; Dimitri Moreau; Christos Roussakis


Letters in Organic Chemistry | 2007

An Efficient Synthesis of Simple β,β -Cyclobisalkylated Melatoninergic Phenylalkylamides

Andrew Tsotinis; Margarita Vlachou; Demetris P. Papahatjis; Spyros P. Nikas; David Sugden

Collaboration


Dive into the Margarita Vlachou's collaboration.

Top Co-Authors

Avatar

Andrew Tsotinis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andreas Eleutheriades

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Spyridon Zouroudis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Lloyd R. Kelland

Institute of Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Jeney

Semmelweis University

View shared research outputs
Researchain Logo
Decentralizing Knowledge